| Literature DB >> 25922074 |
Yan Guo1, Bingfang Hu2, Hai Huang3, Allan Tsung3, Nilesh W Gaikwad4, Meishu Xu5, Mengxi Jiang5, Songrong Ren5, Jie Fan6, Timothy R Billiar3, Min Huang7, Wen Xie8.
Abstract
Estrogen sulfotransferase (EST) regulates estrogen homeostasis by sulfonating and deactivating estrogens. Liver ischemia and reperfusion (I/R) involves both hypoxia during the ischemic phase and oxidative damage during the reperfusion phase. In this report, we showed that the expression of EST was markedly induced by I/R. Mechanistically, oxidative stress-induced activation of Nrf2 was responsible for the EST induction, which was abolished in Nrf2(-/-) mice. EST is a direct transcriptional target of Nrf2. In female mice, the I/R-responsive induction of EST compromised estrogen activity. EST ablation attenuated I/R injury as a result of decreased estrogen deprivation, whereas this benefit was abolished upon ovariectomy. The effect of EST ablation was sex-specific because the EST(-/-) males showed heightened I/R injury. Reciprocally, both estrogens and EST regulate the expression and activity of Nrf2. Estrogen deprivation by ovariectomy abolished the I/R-responsive Nrf2 accumulation, whereas the compromised estrogen deprivation in EST(-/-) mice was associated with increased Nrf2 accumulation. Our results suggested a novel I/R-responsive feedback mechanism to limit the activity of Nrf2 in which Nrf2 induces the expression of EST, which subsequently increases estrogen deactivation and limits the estrogen-responsive activation of Nrf2. Inhibition of EST, at least in females, may represent an effective approach to manage hepatic I/R injury.Entities:
Keywords: Nrf2; estrogen homeostasis; estrogen sulfotransferase; liver ischemia and reperfusion; oxidative stress
Mesh:
Substances:
Year: 2015 PMID: 25922074 PMCID: PMC4505540 DOI: 10.1074/jbc.M115.642124
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157